Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Ysios Capital Partners SGECR S.A.

Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early- and mid-stage, highly innovative life science companies that develop disruptive therapeutic products and platform technologies to address clear medical needs. Founded in 2008, Ysios Capital has €346M in assets under management through its three funds, with a team of 15 investment professionals, 5 venture partners, 2 operational partners and offices in San Sebastián and Barcelona. *


Period Start 2008-01-01 established
  Group Ysios Capital (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Casellas, Marc (SOM Biotech 202106– CFO before Ysios Capital Partners + Danone Group + PwC Consulting)
  Person 2 Jean-Mairet, Joël (Ysios Capital 201206)
Region Region Barcelona
  Country Spain (España)
  Street 11 Travessera de Gràcia
8th Floor
  City 08021 Barcelona
  Tel +34-93-517-3545
    Address record changed: 2021-04-28
Basic data Employees B: 11 to 50 (2015-08-18)
  Currency EUR
  Annual sales 125,000,000 (assets, managed (2015) 2015-08-18)
    * Document for �About Section�: Ona Therapeutics. (6/16/20). "Press Release: Ona Therapeutics Raises €30m in Series A Financing". Barcelona.
Record changed: 2021-05-05


Picture [iito] Made Without Love 650x80px

More documents for Ysios Capital (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top